Ligand · EIQ
EIQ · ~{N}-[4-(pyridin-4-ylmethyl)phenyl]benzenesulfonamide
EIQ, ~{N}-[4-(pyridin-4-ylmethyl)phenyl]benzenesulfonamide (C18 H16 N2 O2 S, 324.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds…
- Component
- EIQ
- Formula
- C18 H16 N2 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
EIQ in 2 structures; the first of them:
- 7QQ7 · Crystal structure of CYP142 from Mycobacterium tuberculosis in complex with an inhibitor… · EIQ A1609 · binds ILE65, LEU72, MET74, ILE76, LEU159, PHE162, LEU163, MET222 and 8 more
- 7ZGL · Crystal structure of CYP125 from Mycobacterium tuberculosis in complex with an inhibitor · EIQ A501 · binds ILE97, GLN112, VAL115, LEU117, ASN118, MET200, SER217, VAL263 and 7 more
Residues it binds most
VAL 4, MET 4, LEU 4, ILE 4, PHE 4, THR 4, ALA 3, ASN 3, GLN 3, TRP 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.